Induction of promyelocytic leukemia (PML) oncogenic domains (PODs) by papillomavirus

Virology

Volumn 366, Issue 2, 2007, Pages 316-329

  Nakahara, Tomomi ^a   Lambert, Paul F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Papillomavirus; PML; Raft cultures; Viral DNA replication; Viral transcription

Indexed keywords

ARTICLE; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL STRUCTURE; DNA REPLICATION; DNA TRANSCRIPTION; DNA VIRUS; EPITHELIUM; GENOME; HOST; KERATINOCYTE; LIFE CYCLE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROCESSING; VIRUS MORPHOLOGY; WART VIRUS;

CELL NUCLEUS STRUCTURES; CELLS, CULTURED; HUMANS; KERATINOCYTES; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PAPILLOMAVIRIDAE; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; VIRAL PROTEINS; VIRUS REPLICATION;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 34548561734     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.04.032     Document Type: Article

References (87)

1. Ahn J.H., and Hayward G.S. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J. Virol. 71 6 (1997) 4599-4613
2. Ahuja D., Saenz-Robles M.T., and Pipas J.M. SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24 52 (2005) 7729-7745
3. Becker K.A., Florin L., Sapp C., and Sapp M. Dissection of human papillomavirus type 33 L2 domains involved in nuclear domains (ND) 10 homing and reorganization. Virology 314 1 (2003) 161-167
4. Becker K.A., Florin L., Sapp C., Maul G.G., and Sapp M. Nuclear localization but not PML protein is required for incorporation of the papillomavirus minor capsid protein L2 into virus-like particles. J. Virol. 78 3 (2004) 1121-1128
5. Beech S.J., Lethbridge K.J., Killick N., McGlincy N., and Leppard K.N. Isoforms of the promyelocytic leukemia protein differ in their effects on ND10 organization. Exp. Cell Res. 307 1 (2005) 109-117
6. Bischof O., Nacerddine K., and Dejean A. Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways. Mol. Cell. Biol. 25 3 (2005) 1013-1024
7. Block G.J., Eskiw C.H., Dellaire G., and Bazett-Jones D.P. Transcriptional regulation is affected by subnuclear targeting of reporter plasmids to PML nuclear bodies. Mol. Cell. Biol. 26 23 (2006) 8814-8825
8. Boddy M.N., Howe K., Etkin L.D., Solomon E., and Freemont P.S. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene 13 5 (1996) 971-982
9. Boe S.O., Haave M., Jul-Larsen A., Grudic A., Bjerkvig R., and Lonning P.E. Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA. J. Cell Sci. 119 Pt. 16 (2006) 3284-3295
10. Borden K.L. Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol. Cell. Biol. 22 15 (2002) 5259-5269
11. Burkham J., Coen D.M., and Weller S.K. ND10 protein PML is recruited to herpes simplex virus type 1 prereplicative sites and replication compartments in the presence of viral DNA polymerase. J. Virol. 72 12 (1998) 10100-10107
12. Chang K.S., Fan Y.H., Andreeff M., Liu J., and Mu Z.M. The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood 85 12 (1995) 3646-3653
13. Chee A.V., Lopez P., Pandolfi P.P., and Roizman B. Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J. Virol. 77 12 (2003) 7101-7105
14. Chelbi-Alix M.K., Pelicano L., Quignon F., Koken M.H., Venturini L., Stadler M., Pavlovic J., Degos L., and de The H. Induction of the PML protein by interferons in normal and APL cells. Leukemia 9 12 (1995) 2027-2033
15. Crusius K., Auvinen E., and Alonso A. Enhancement of EGF- and PMA-mediated MAP kinase activation in cells expressing the human papillomavirus type 16 E5 protein. Oncogene 15 12 (1997) 1437-1444
16. Crusius K., Rodriguez I., and Alonso A. The human papillomavirus type 16 E5 protein modulates ERK1/2 and p38 MAP kinase activation by an EGFR-independent process in stressed human keratinocytes. Virus Genes 20 1 (2000) 65-69
17. Day P.M., Roden R.B., Lowy D.R., and Schiller J.T. The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein. E2, to PML oncogenic domains. J. Virol. 72 1 (1998) 142-150
18. Day P.M., Baker C.C., Lowy D.R., and Schiller J.T. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc. Natl. Acad. Sci. U.S.A. 101 39 (2004) 14252-14257
19. Dellaire G., and Bazett-Jones D.P. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. BioEssays 26 9 (2004) 963-977
20. Dellaire G., Ching R.W., Ahmed K., Jalali F., Tse K.C., Bristow R.G., and Bazett-Jones D.P. Promyelocytic leukemia nuclear bodies behave as DNA damage sensors whose response to DNA double-strand breaks is regulated by NBS1 and the kinases ATM, Chk2, and ATR. J. Cell Biol. 175 1 (2006) 55-66
21. Dohmen R.J. SUMO protein modification. Biochim. Biophys. Acta 1695 1-3 (2004) 113-131
22. Eskiw C.H., Dellaire G., Mymryk J.S., and Bazett-Jones D.P. Size, position and dynamic behavior of PML nuclear bodies following cell stress as a paradigm for supramolecular trafficking and assembly. J. Cell Sci. 116 Pt. 21 (2003) 4455-4466
23. Everett R.D. DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20 49 (2001) 7266-7273
24. Everett R.D., and Murray J. ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J. Virol. 79 8 (2005) 5078-5089
25. Everett R.D., Freemont P., Saitoh H., Dasso M., Orr A., Kathoria M., and Parkinson J. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J. Virol. 72 8 (1998) 6581-6591
26. Everett R.D., Lomonte P., Sternsdorf T., van Driel R., and Orr A. Cell cycle regulation of PML modification and ND10 composition. J. Cell Sci. 112 Pt. 24 (1999) 4581-4588
27. Everett R.D., Sourvinos G., and Orr A. Recruitment of herpes simplex virus type 1 transcriptional regulatory protein ICP4 into foci juxtaposed to ND10 in live, infected cells. J. Virol. 77 6 (2003) 3680-3689
28. Everett R.D., Sourvinos G., Leiper C., Clements J.B., and Orr A. Formation of nuclear foci of the herpes simplex virus type 1 regulatory protein ICP4 at early times of infection: localization, dynamics, recruitment of ICP27, and evidence for the de novo induction of ND10-like complexes. J. Virol. 78 4 (2004) 1903-1917
29. Everett R.D., Rechter S., Papior P., Tavalai N., Stamminger T., and Orr A. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J. Virol. 80 16 (2006) 7995-8005
30. Fehrmann F., Klumpp D.J., and Laimins L.A. Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J. Virol. 77 5 (2003) 2819-2831
31. Flores E.R., Allen-Hoffmann B.L., Lee D., and Lambert P.F. The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle. J. Virol. 74 14 (2000) 6622-6631
32. Florin L., Sapp C., Streeck R.E., and Sapp M. Assembly and translocation of papillomavirus capsid proteins. J. Virol. 76 19 (2002) 10009-10014
33. Genther S.M., Sterling S., Duensing S., Munger K., Sattler C., and Lambert P.F. Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle. J. Virol. 77 5 (2003) 2832-2842
34. Guccione E., Lethbridge K.J., Killick N., Leppard K.N., and Banks L. HPV E6 proteins interact with specific PML isoforms and allow distinctions to be made between different POD structures. Oncogene 23 27 (2004) 4662-4672
35. Guo A., Salomoni P., Luo J., Shih A., Zhong S., Gu W., and Pandolfi P.P. The function of PML in p53-dependent apoptosis. Nat. Cell Biol. 2 10 (2000) 730-736
36. Hayakawa F., and Privalsky M.L. Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis. Cancer Cell 5 4 (2004) 389-401
37. Heino P., Zhou J., and Lambert P.F. Interaction of the papillomavirus transcription/replication factor, E2, and the viral capsid protein, L2. Virology 276 2 (2000) 304-314
38. Helt A.M., and Galloway D.A. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 24 2 (2003) 159-169
39. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26 2 (1967) 365-369
40. Holmgren S.C., Patterson N.A., Ozbun M.A., and Lambert P.F. The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle. J. Virol. 79 7 (2005) 3938-3948
41. Howley P.M., and Lowy D.R. Papillomaviruses and their replication. Fields Virology. 4th ed. (2001), Lippincott Williams & Wilkins, Philadelphia, PA 2197-2229
42. Ishov A.M., and Maul G.G. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J. Cell Biol. 134 4 (1996) 815-826
43. Ishov A.M., Sotnikov A.G., Negorev D., Vladimirova O.V., Neff N., Kamitani T., Yeh E.T., Strauss III J.F., and Maul G.G. PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147 2 (1999) 221-234
44. Jeon S., and Lambert P.F. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 92 5 (1995) 1654-1658
45. Jul-Larsen A., Visted T., Karlsen B.O., Rinaldo C.H., Bjerkvig R., Lonning P.E., and Boe S.O. PML-nuclear bodies accumulate DNA in response to polyomavirus BK and simian virus 40 replication. Exp. Cell Res. 298 1 (2004) 58-73
46. Kieback E., and Muller M. Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein. Virology 345 1 (2006) 199-208
47. Kim K., Garner-Hamrick P.A., Fisher C., Lee D., and Lambert P.F. Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J. Virol. 77 23 (2003) 12450-12459
48. Kirnbauer R., Taub J., Greenstone H., Roden R., Durst M., Gissmann L., Lowy D.R., and Schiller J.T. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67 12 (1993) 6929-6936
49. Korioth F., Maul G.G., Plachter B., Stamminger T., and Frey J. The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp. Cell Res. 229 1 (1996) 155-158
50. Lambert P.F. Papillomavirus DNA replication. J. Virol. 65 7 (1991) 3417-3420
51. Lambert P.F., Baker C.C., and Howley P.M. The genetics of bovine papillomavirus type 1. Annu. Rev. Genet. 22 (1988) 235-258
52. Lambert P.F., Monk B.C., and Howley P.M. Phenotypic analysis of bovine papillomavirus type 1 E2 repressor mutants. J. Virol. 64 2 (1990) 950-956
53. Lambert P.F., Ozbun M.A., Collins A., Holmgren S., Lee D., and Nakahara T. Using an immortalized cell line to study the HPV life cycle in organotypic "raft" cultures. Methods Mol. Med. 119 (2005) 141-155
54. Lavau C., Marchio A., Fagioli M., Jansen J., Falini B., Lebon P., Grosveld F., Pandolfi P.P., Pelicci P.G., and Dejean A. The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene 11 5 (1995) 871-876
55. Law M.F., Lowy D.R., Dvoretzky I., and Howley P.M. Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences. Proc. Natl. Acad. Sci. U.S.A. 78 5 (1981) 2727-2731
56. Leppard K.N., and Everett R.D. The adenovirus type 5 E1b 55K and E4 Orf3 proteins associate in infected cells and affect ND10 components. J. Gen. Virol. 80 Pt. 4 (1999) 997-1008
57. Lin D.Y., Lai M.Z., Ann D.K., and Shih H.M. Promyelocytic leukemia protein (PML) functions as a glucocorticoid receptor co-activator by sequestering Daxx to the PML oncogenic domains (PODs) to enhance its transactivation potential. J. Biol. Chem. 278 18 (2003) 15958-15965
58. Lowy D.R., Dvoretzky I., Shober R., Law M.F., Engel L., and Howley P.M. In vitro tumorigenic transformation by a defined sub-genomic fragment of bovine papilloma virus DNA. Nature 287 5777 (1980) 72-74
59. Maul G.G., Guldner H.H., and Spivack J.G. Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J. Gen. Virol. 74 Pt. 12 (1993) 2679-2690
60. Maul G.G., Negorev D., Bell P., and Ishov A.M. Review: properties and assembly mechanisms of ND10, PML bodies, or PODs. J. Struct. Biol. 129 2-3 (2000) 278-287
61. Middleton K., Peh W., Southern S., Griffin H., Sotlar K., Nakahara T., El-Sherif A., Morris L., Seth R., Hibma M., Jenkins D., Lambert P., Coleman N., and Doorbar J. Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J. Virol. 77 19 (2003) 10186-10201
62. Muller S., and Dejean A. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J. Virol. 73 6 (1999) 5137-5143
63. Munger K., Baldwin A., Edwards K.M., Hayakawa H., Nguyen C.L., Owens M., Grace M., and Huh K. Mechanisms of human papillomavirus-induced oncogenesis. J. Virol. 78 21 (2004) 11451-11460
64. Nakahara T., Peh W.L., Doorbar J., Lee D., and Lambert P.F. Human papillomavirus type 16 E1circumflexE4 contributes to multiple facets of the papillomavirus life cycle. J. Virol. 79 20 (2005) 13150-13165
65. Pearson M., and Pelicci P.G. PML interaction with p53 and its role in apoptosis and replicative senescence. Oncogene 20 49 (2001) 7250-7256
66. Petti L., Nilson L.A., and DiMaio D. Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein. EMBO J. 10 4 (1991) 845-855
67. Puvion-Dutilleul F., Chelbi-Alix M.K., Koken M., Quignon F., Puvion E., and de The H. Adenovirus infection induces rearrangements in the intranuclear distribution of the nuclear body-associated PML protein. Exp. Cell Res. 218 1 (1995) 9-16
68. Puvion-Dutilleul F., Venturini L., Guillemin M.C., de The H., and Puvion E. Sequestration of PML and Sp100 proteins in an intranuclear viral structure during herpes simplex virus type 1 infection. Exp. Cell Res. 221 2 (1995) 448-461
69. Regad T., and Chelbi-Alix M.K. Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 20 49 (2001) 7274-7286
70. Roberts S., Hillman M.L., Knight G.L., and Gallimore P.H. The ND10 component promyelocytic leukemia protein relocates to human papillomavirus type 1 E4 intranuclear inclusion bodies in cultured keratinocytes and in warts. J. Virol. 77 1 (2003) 673-684
71. Sanz M.M., Proytcheva M., Ellis N.A., Holloman W.K., and German J. BLM, the Bloom's syndrome protein, varies during the cell cycle in its amount, distribution, and co-localization with other nuclear proteins. Cytogenet. Cell Genet. 91 1-4 (2000) 217-223
72. Stadler M., Chelbi-Alix M.K., Koken M.H., Venturini L., Lee C., Saib A., Quignon F., Pelicano L., Guillemin M.C., Schindler C., et al. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11 12 (1995) 2565-2573
73. Swindle C.S., Zou N., Van Tine B.A., Shaw G.M., Engler J.A., and Chow L.T. Human papillomavirus DNA replication compartments in a transient DNA replication system. J. Virol. 73 2 (1999) 1001-1009
74. Tang Q., Bell P., Tegtmeyer P., and Maul G.G. Replication but not transcription of simian virus 40 DNA is dependent on nuclear domain 10. J. Virol. 74 20 (2000) 9694-9700
75. Taylor E.R., Dornan E.S., Boner W., Connolly J.A., McNair S., Kannouche P., Lehmann A.R., and Morgan I.M. The fidelity of HPV16 E1/E2-mediated DNA replication. J. Biol. Chem. 278 52 (2003) 52223-52230
76. Thomas J.T., Hubert W.G., Ruesch M.N., and Laimins L.A. Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc. Natl. Acad. Sci. U.S.A. 96 15 (1999) 8449-8454
77. Vallian S., Gaken J.A., Gingold E.B., Kouzarides T., Chang K.S., and Farzaneh F. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein. Oncogene 16 22 (1998) 2843-2853
78. Wilkinson D.E., and Weller S.K. Recruitment of cellular recombination and repair proteins to sites of herpes simplex virus type 1 DNA replication is dependent on the composition of viral proteins within prereplicative sites and correlates with the induction of the DNA damage response. J. Virol. 78 9 (2004) 4783-4796
79. Wilson R., Fehrmann F., and Laimins L.A. Role of the E1-E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31. J. Virol. 79 11 (2005) 6732-6740
80. Yang H.Y., Fratta W., Majane E.A., and Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc. Natl. Acad. Sci. U.S.A. 82 22 (1985) 7757-7761
81. Yang S., Kuo C., Bisi J.E., and Kim M.K. PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2. Nat. Cell Biol. 4 11 (2002) 865-870
82. Yankiwski V., Noonan J.P., and Neff N.F. The C-terminal domain of the Bloom syndrome DNA helicase is essential for genomic stability. BMC Cell Biol. 2 (2001) 11
83. Zheng P., Guo Y., Niu Q., Levy D.E., Dyck J.A., Lu S., Sheiman L.A., and Liu Y. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation. Nature 396 6709 (1998) 373-376
84. Zhong S., Muller S., Ronchetti S., Freemont P.S., Dejean A., and Pandolfi P.P. Role of SUMO-1-modified PML in nuclear body formation. Blood 95 9 (2000) 2748-2752
85. Zhong S., Salomoni P., and Pandolfi P.P. The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2 5 (2000) E85-E90
86. Zhu J., Koken M.H., Quignon F., Chelbi-Alix M.K., Degos L., Wang Z.Y., Chen Z., and de The H. Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 94 8 (1997) 3978-3983
87. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev., Cancer 2 5 (2002) 342-350